Literature DB >> 25559039

Technetium-99m and rhenium-188 complexes with one and two pendant bisphosphonate groups for imaging arterial calcification.

Jayanta Kumar Bordoloi1, David Berry, Irfan Ullah Khan, Kavitha Sunassee, Rafael Torres Martin de Rosales, Catherine Shanahan, Philip J Blower.   

Abstract

The first (99m)Tc and (188)Re complexes containing two pendant bisphosphonate groups have been synthesised, based on the mononuclear M(v) nitride core with two dithiocarbamate ligands each with a pendant bisphosphonate. The structural identity of the (99)Tc and stable rhenium analogues as uncharged, mononuclear nitridobis(dithiocarbamate) complexes was determined by electrospray mass spectrometry. The (99m)Tc complex showed greater affinity for synthetic and biological hydroxyapatite, and greater stability in biological media, than the well-known but poorly-characterised and inhomogeneous bone imaging agent (99m)Tc-MDP. It gave excellent SPECT images of both bone calcification (mice and rats) and vascular calcification (rat model), but the improved stability and the availability of two pendant bisphosphonate groups conferred no dramatic advantage in imaging over the conventional (99m)Tc-MDP agent in which the bisphosphonate group is bound directly to Tc. The (188)Re complex also showed preferential uptake in bone. These tracers and the biological model of vascular calcification offer the opportunity to study the biological interpretation and clinical potential of radionuclide imaging of vascular calcification and to deliver radionuclide therapy to bone metastases.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25559039      PMCID: PMC6211635          DOI: 10.1039/c4dt02965h

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  28 in total

1.  Reduction-mediated technetium-99m labeling of monoclonal antibodies.

Authors:  S J Mather; D Ellison
Journal:  J Nucl Med       Date:  1990-05       Impact factor: 10.057

2.  Extending the life of a 99Tcm generator: a simple and convenient method for concentrating generator eluate for clinical use.

Authors:  P J Blower
Journal:  Nucl Med Commun       Date:  1993-11       Impact factor: 1.690

3.  Rhenium-186-labeled hydroxyethylidene diphosphonate dosimetry and dosing guidelines for the palliation of skeletal metastases from androgen-independent prostate cancer.

Authors:  M C Graham; H I Scher; G B Liu; S D Yeh; T Curley; F Daghighian; S J Goldsmith; S M Larson
Journal:  Clin Cancer Res       Date:  1999-06       Impact factor: 12.531

4.  Warfarin-induced artery calcification is accelerated by growth and vitamin D.

Authors:  P A Price; S A Faus; M K Williamson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-02       Impact factor: 8.311

5.  Biodistribution of anionic separated MDP complexes from different MDP preparations.

Authors:  A Handeland; M W Lindegaard; D E Heggli
Journal:  Eur J Nucl Med       Date:  1989

6.  Rhenium-188 and technetium-99m nitridobis(N-ethoxy-N-ethyldithiocarbamate) leucocyte labelling radiopharmaceuticals: [188ReN(NOET)2] and [99mTcN(NOET)2], NOET = Et(EtO)NCS2: their in vitro localization and chemical behaviour.

Authors:  F Demaimay; L Dazord; A Roucoux; N Noiret; H Patin; A Moisan
Journal:  Nucl Med Biol       Date:  1997-11       Impact factor: 2.408

7.  Intratumoral injection of rhenium-188 microspheres into an animal model of hepatoma.

Authors:  S J Wang; W Y Lin; M N Chen; C S Chi; J T Chen; W L Ho; B T Hsieh; L H Shen; Z T Tsai; G Ting; S Mirzadeh; F F Knapp
Journal:  J Nucl Med       Date:  1998-10       Impact factor: 10.057

8.  Pharmacokinetics of rhenium-186 after administration of rhenium-186-HEDP to patients with bone metastases.

Authors:  J M de Klerk; A van Dijk; A D van het Schip; B A Zonnenberg; P P van Rijk
Journal:  J Nucl Med       Date:  1992-05       Impact factor: 10.057

9.  High-yield synthesis of the terminal 188Re triple bond N multiple bond from generator-produced [188ReO4](-).

Authors:  Alessandra Boschi; Cristina Bolzati; Licia Uccelli; Adriano Duatti
Journal:  Nucl Med Biol       Date:  2003-05       Impact factor: 2.408

10.  Studies on the preparation and isomeric composition of 186Re- and 188Re-pentavalent rhenium dimercaptosuccinic acid complex.

Authors:  J Singh; K Reghebi; C R Lazarus; S E Clarke; A P Callahan; F F Knapp; P J Blower
Journal:  Nucl Med Commun       Date:  1993-03       Impact factor: 1.690

View more
  4 in total

1.  Synthesis and Characterization of Novel [2 + 1] Tricarbonyl Rhenium Complexes with the Hydrophilic Phosphine Ligands PTA and CAP.

Authors:  Ioanna Roupa; Charalampos Flampouraris; Antonio Shegani; Myrto Ischyropoulou; Konstantina Makrypidi; Catherine Raptopoulou; Ioannis Pirmettis; Minas S Papadopoulos; Vassilis Psycharis; Aristeidis Chiotellis
Journal:  Bioinorg Chem Appl       Date:  2022-06-13       Impact factor: 4.724

2.  One-step, kit-based radiopharmaceuticals for molecular SPECT imaging: a versatile diphosphine chelator for 99mTc radiolabelling of peptides.

Authors:  Ingebjørg N Hungnes; Fahad Al-Salemee; Peter J Gawne; Thomas Eykyn; R Andrew Atkinson; Samantha Y A Terry; Fiona Clarke; Philip J Blower; Paul G Pringle; Michelle T Ma
Journal:  Dalton Trans       Date:  2021-11-16       Impact factor: 4.390

3.  Opportunities and challenges for metal chemistry in molecular imaging: from gamma camera imaging to PET and multimodality imaging.

Authors:  Richard Southworth; Rafael Torres Martin de Rosales; Levente K Meszaros; Michelle T Ma; Gregory E D Mullen; Gilbert Fruhwirth; Jennifer D Young; Cinzia Imberti; Julia Bagunya-Torres; Erica Andreozzi; Philip J Blower
Journal:  Adv Inorg Chem       Date:  2015-11-16       Impact factor: 3.282

4.  HAP-Multitag, a PET and Positive MRI Contrast Nanotracer for the Longitudinal Characterization of Vascular Calcifications in Atherosclerosis.

Authors:  Juan Pellico; Irene Fernández-Barahona; Jesús Ruiz-Cabello; Lucía Gutiérrez; María Muñoz-Hernando; María J Sánchez-Guisado; Irati Aiestaran-Zelaia; Lydia Martínez-Parra; Ignacio Rodríguez; Jacob Bentzon; Fernando Herranz
Journal:  ACS Appl Mater Interfaces       Date:  2021-09-16       Impact factor: 9.229

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.